Compliance In Focus

Running a clinical trial is a tremendous effort, requiring extensive resources.  No company wants to spend any more effort than required to get their product to market.  A recent whitepaper published by ImageIQ talks discusses the application of preclinical study in clinical trials to help save time and money.

IMARC Research, a  CRO offering monitoring, auditing and training services  and ImageIQ, an imaging contract research organization (CRO) and, have announced a partnership that will strengthen the abilities of both organization’s clients to manage the complexities of imaging within clinical trials, and to enhance FDA approvals by ensuring that scientific data is optimized and that processes are compliant.  ImageIQ will provide IMARC clients with their imaging and image analysis clinical trial expertise.  Conversely, IMARC will bring its 14 years of clinical trial management experience to ImageIQ clients that utilize ImageIQ’s imaging analytics and software development expertise.

In clinical research having a well-run, compliant study is a top priority. Ensuring patients are protected and resulting data has integrity, it’s important to be experts in all aspects of your study. If your trial involves imaging, understanding how to get the most out of your data is not only smart- it’s cost effective. From a recent article published on GEN - Genetic Engineering & Biotechnology news, here are nine tips to help bring products to market faster with these ways of optimizing preclinical imaging:

For all clinical trials, operating in compliance with the federal regulations, the agreements, the investigational plan, and the requirements of the IRB are critical to protect human subjects and to demonstrate quality and integrity of the resulting data. When imaging is introduced into a clinical research trial, a new layer of complexity is added, and additional considerations with regard to helping sites maintain compliance with the imaging requirements should be implemented.